MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/hep.25658

Медицинская библиотека · Hepatology (Baltimore, Md.) · 2012

Long-term outcome of Japanese patients with type 1 autoimmune hepatitis.

Yoshizawa Kaname, Matsumoto Akihiro, Ichijo Tetsuya, Umemura Takeji, Joshita Satoru, Komatsu Michiharu, Tanaka Naoki, Tanaka Eiji, Ota Masao, Katsuyama Yoshihiko, Kiyosawa Kendo, Abe Masanori, Onji Morikazu

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

UNLABELLED: The long-term outcome of patients with autoimmune hepatitis (AIH) in Japan has not been well-defined. The aim of this study was to clarify the outcome of this disease over a long follow-up period compared with that of the general Japanese population as well as that among patients. A total of 203 AIH patients were enrolled for a mean follow-up period of 131 months. All patients were treated with corticosteroids with or without azathioprine. The overall survival of AIH patients was similar to that of the general population in Japan. The prognosis of AIH subgroups divided according to disease severity, sex, incidence of relapse, liver histology, presence of cirrhosis, probable or definite AIH score, antibody to hepatitis B core antigen antibody positivity, or human leukocyte antigen DR4-positivity did not differ greatly among patients. However, the prognosis of patients experiencing two or more relapses was significantly poorer than that of patients with remission or a single relapse both in univariate (P < 0.001) and multivariate (P = 0.020) analyses. The development of liver malignancy was also a possibility among AIH patients with multiple relapses. Severe adverse effects of corticosteroids were rare, even in patients who underwent long-term treatment.

CONCLUSION

Repeated relapses of AIH are significantly associated with a poorer long-term prognosis in Japan. AIH patients can expect a similar prognosis to that of the general population, provided they are adequately managed with continuous low doses of immunosuppressive therapy, especially after the first relapse.

Для цитирования: Yoshizawa Kaname, Matsumoto Akihiro, Ichijo Tetsuya, Umemura Takeji, Joshita Satoru, Komatsu Michiharu, Tanaka Naoki, Tanaka Eiji, Ota Masao, Katsuyama Yoshihiko, Kiyosawa Kendo, Abe Masanori, Onji Morikazu. Long-term outcome of Japanese patients with type 1 autoimmune hepatitis.. Hepatology (Baltimore, Md.). 2012. DOI: 10.1002/hep.25658.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.